Skip to main content

Efficacy of oral rinse and other detection methods in detecting oral human papillomavirus infections: The Oromouth cohort study.

The Journal of infection2025-02-09PubMed
Total: 69.5Innovation: 6Impact: 7Rigor: 8Citation: 6

Summary

In a 945-participant cohort undergoing tonsillectomy, oral rinse yielded the highest detection of oral HPV but still missed 73% of high-risk infections identified by other oral sites. Adding pharyngeal wall, tongue base, and tonsil sampling increased high-risk HPV detections by 38% over oral rinse alone, while serology added little.

Key Findings

  • Combined multi-site sampling yielded HR-HPV prevalence of 4.3% and any HPV prevalence of 18%.
  • Oral rinse alone had HR-HPV detection of 4.0% but missed 73% (11/15) of HR-HPV positives identified at other oral sites.
  • Adding pharyngeal wall, tongue base, and tonsil sampling increased HR-HPV detections by 38% (11/29) over oral rinse alone; serology added minimal value.

Clinical Implications

Screening and surveillance protocols should consider multi-site sampling or validated adjunct methods rather than relying solely on oral rinse, to avoid underestimating high-risk HPV prevalence.

Why It Matters

These data challenge reliance on oral rinse alone for epidemiologic estimates and screening of oral HPV, with direct implications for vaccine impact assessments and trial endpoints.

Limitations

  • Population limited to patients undergoing tonsillectomy, potentially limiting generalizability
  • Cross-sectional sampling without longitudinal persistence assessment
  • Potential sampling variability across oral sites

Future Directions

Standardize multi-site sampling protocols, evaluate cost-effectiveness, and assess longitudinal persistence and transmission risk across sites to inform screening strategies.

Study Information

Study Type
Cohort
Research Domain
Diagnosis
Evidence Level
II - Prospective cohort evaluating detection performance across multiple oral sampling sites.
Study Design
OTHER